Medicine guide

Dapagliflozin Polpharma

On the Bulgarian pack: Дапаглифлозин Полфарма 10 mg филмирани таблетки

10 mg · film-coated tablets

  • Prescription only
  • Digestion, stomach, diabetes and nutrition
Active substance
Dapagliflozin
Made by
Zaklady Farmaceutyczne POLPHARMA SA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupDigestion, stomach, diabetes and nutritionA10BK01

Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet

How it works

This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (dapagliflozin). It describes the substance, not this Bulgarian product — its uses and doses can differ.

Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen.

Dapagliflozin is an inhibitor of SGLT2.

Peak level after2 h
Half-life12.9 h
Mostly cleared after≈ 3 daysfive half-lives — our arithmetic
PeakHalf gone3 days0
The shape is a standard model drawn from the two times above, not a measurement. How fast a medicine acts and wears off also depends on the dose, the form and the person.
How the body breaks it down

The metabolism of dapagliflozin is primarily mediated by UGT1A9; CYP-mediated metabolism is a minor clearance pathway in humans.

How it leaves the body

Dapagliflozin and related metabolites are primarily eliminated via the renal pathway.

With food

Administration of dapagliflozin with a high-fat meal decreases its C max by up to 50% and prolongs T max by approximately 1 hour but does not alter AUC as compared with the fasted state.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-08

Safety of the active substance

This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (dapagliflozin). It describes the substance, not this Bulgarian product — its uses and doses can differ.

Must not be used by
  • Dapagliflozin is contraindicated in patients with a history of a serious hypersensitivity reaction to dapagliflozin or any of the excipients in dapagliflozin.
  • Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with dapagliflozin [see Adverse Reactions ( 6.1 )].
  • History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in dapagliflozin.
Most common side effects

The most frequently reported genital mycotic infections were vulvovaginal mycotic infections in females and balanitis in males.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byZaklady Farmaceutyczne POLPHARMA SA · Poland
Active substanceDapagliflozin
Used inDigestion, stomach, diabetes and nutrition
Strength10 mg
Formfilm-coated tablets
Pack sizes30 · 60 · 90 · 98
ClassificationA10BK01 · Digestion, stomach, diabetes and nutrition
Name in the registerДапаглифлозин Полфарма 10 mg филмирани таблетки
Reg. no.20230137

Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician

Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Other strengths and forms

8 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.